Trials / Completed
CompletedNCT04582097
Ramipril in Pediatric Patients on Hemodialysis
Impact of Angiotensin-converting Enzyme Inhibitor on Pediatric Hemodialysis Patients
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 135 (actual)
- Sponsor
- Ain Shams University · Academic / Other
- Sex
- All
- Age
- 8 Years – 16 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to evaluate the effect of Ramipril in pediatric patients on regular hemodilaysis
Detailed description
Evaluate the effect of Ramipril on blood pressure, heart rate, Endothelial dysfunction and inflammatory markers in pediatric patients on regular hemodilaysis and the correlation of response with ACE I/D polymorphisms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ramipril | angiotensin-converting enzyme inhibitor |
| DRUG | placebo | same odor, color and size as the drug but without the active ingredient |
Timeline
- Start date
- 2018-12-01
- Primary completion
- 2019-03-01
- Completion
- 2020-02-28
- First posted
- 2020-10-09
- Last updated
- 2020-10-14
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04582097. Inclusion in this directory is not an endorsement.